Who We Are - FibroBiologics Fibrobiologics is a fibroblast biopharmaceutical company develops biologic treatments and potential cures for chronic diseases
FibroBiologics, Inc. (FBLG) FibroBiologics is a cell therapy, regenerative medicine company developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials FibroBiologics holds 150+ US and…
Pipeline - FibroBiologics Leveraging Fibroblast Technology Our Product Pipeline Our Product Pipeline FibroBiologics has been a pioneer in regenerative medicine for over 2 years and holds over 150+ patents CYWC628 Wound Healing Accelerate wound healing Recruit stem cells for tissue remodeling li> Potential use in DFUs, VLUs, burn, etc li> CYMS101 Multiple Sclerosis Stimulates Remyelination Stimulates Endogenous Neural
Press Releases :: FibroBiologics, Inc. (FBLG) FibroBiologics Presents Novel Thymus Organoid Platform to Combat Age-Related Immune Decline at Keystone Symposia on Aging and Immunity
FibroBiologics Files Patent Application Covering Novel Fibroblast-Based . . . About FibroBiologics Based in Houston, FibroBiologics is a clinical-stage biotechnology company developing a pipeline of treatments and seeking potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials
FibroBiologics Advancing Development of a Fibroblast Treatment for . . . About FibroBiologics Based in Houston, FibroBiologics is a clinical-stage biotechnology company developing a pipeline of treatments and seeking potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials
FibroBiologics Announces Direct Listing on NASDAQ Under the Stock . . . HOUSTON, Jan 31, 2024 PRNewswire -- FibroBiologics, Inc (NASDAQ: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company focused on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, announced that trading of the FibroBiologics stock commenced today on Nasdaq under the stock ticker FBLG